Evidence map›Paper›PMID 40290326›Full record

ArticleThe Pan African medical journal2025

[Plasma cell leukemia: new diagnostic and therapeutic perspectives (about five cases)].

Assya Khermach, Meryem Sabia, Nisma Douzi, Abdelilah Berhili, Mounia Slaoui, Mohammed Bensalah, Rachid Seddik

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Assya KhermachFaculté de Médecine et de Pharmacie, Oujda, Maroc.
Meryem SabiaFaculté de Médecine et de Pharmacie, Oujda, Maroc.
Nisma DouziFaculté de Médecine et de Pharmacie, Oujda, Maroc.
Abdelilah BerhiliLaboratoire d'Hématologie, CHU Mohammed VI, Oujda, Maroc.
Mounia SlaouiLaboratoire d'Hématologie, CHU Mohammed VI, Oujda, Maroc.
Mohammed BensalahFaculté de Médecine et de Pharmacie, Oujda, Maroc.
Rachid SeddikFaculté de Médecine et de Pharmacie, Oujda, Maroc.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma cell leukemia (PCL) is a rare lymphoproliferative disorder characterized by clonal proliferation of plasma cells in the bone marrow and peripheral blood. In 2021, the International Myeloma Working Group (IMWG) redefined LCP as the presence of 5% or more circulating plasma cells in patients otherwise diagnosed with multiple myeloma. In this work, we report five cases of PCL collected in the hematology laboratory of the Mohammed VI University Hospital in Oujda. The interest of this work is to elucidate the importance of hematological cytology in diagnostic guidance as well as therapeutic innovation concerning this rare pathology.

Indexed as

Leukemia, Plasma CellMultiple MyelomaPlasma CellsHospitals, UniversityHumansMoroccobortezomibcase reportLeukemiamultiple myelomaplasmocyte

Identifiers

PMID40290326
PMCPMC12032612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.